2-[2-(Benzo[d][1,3]dioxol-5-ylcarbamoyl)phenyl]acetic acid, 98.0%, 1g

(R)-2-Amino-3-ethylpentanoic acid, 95+%, 250mg

quinoxaline-5-carboxylic acid, 95.0%, 1g

Verres à centrifuger 15 ml avec bord perlé, avec graduations, 1-15 ml, 100 Pièce(s)

(5-Chloro-2-methyl-1H-indol-3-yl)-acetic acid, 95.0%, 1g

3-Bromo-1-triisopropylsilyl pyrrole, 97%, 25g

7-[(4-methoxyphenyl)methyl]-5-methyl-1H,4H,5H,6H,7H-pyrazolo[3,4-d]pyrimidine-4,6-dione, 97%, 250mg

Thalidomide-NH-PEG2-C2-NH-Boc, 250mg

(4-(Aminomethyl)-3-methylphenyl)(2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)methanone, 97%, 1g

2-(2,2,2-Trifluoroethoxy)aniline, 95.0%, 5g

2-Chloro-6-phenoxypyrazine, 97.0%, 250mg

1-(2-(DIFLUOROMETHOXY)PHENYL)ETHAN-1-OL, 95.0%, 250mg

1,1,3,3-Tetramethoxypropane, 98.0%, 25g